 LOS ANGELES, Jan. 18, 2023 GLOBE NEWSWIRE Trethera Corporation Trethera, a clinical-stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today the appointment of Boyd Quinnell, CPA, MBA, to the Trethera Board of Directors as an independent director. A veteran healthcare executive with ... The post Trethera Announces Appointment of R. Boyd Quinnell to Board of Directors appeared f... 